Product Program year 2025 Source: CMS Open Payments

Btod

Device Ophthalmology

Open in the dashboard

General payments

$476,419

15,325 payments

Research payments

$0

0 payments

Through program year 2025, $476,419 in general payments and $0 in research payments were reported against Btod (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $22,866 614
2024 General $15,226 520
2023 General $7,132 256
2022 General $62,158 1,826
2021 General $100,579 3,757
2020 General $93,397 3,416
2019 General $175,062 4,936

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb, a division of Bausch Health US, LLC $369,012 12,107 payments
  2. Bausch & Lomb Americas Inc. $107,381 3,216 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $26 2 payments
Top recipients General payments · program year 2025
  1. Christopher Rafalski Optometrist · Mission Viejo, CA $562 2% · 5 payments
  2. Alan Cheung Optometrist · Los Angeles, CA $453 2% · 4 payments
  3. Charles Luu Optometrist · Fullerton, CA $339 1% · 4 payments
  4. Lynne Louie Luu Optometrist · Westminster, CA $319 1% · 3 payments
  5. Jim Chan Optometrist, Corneal and Contact Management · Arcadia, CA $241 1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Optometrist $22,150 97% · 418 practitioners
  2. Optometrist, Corneal and Contact Management Optometrist $384 2% · 5 practitioners
  3. Ophthalmology $275 1% · 5 practitioners
  4. Optometrist, Pediatrics Optometrist $34 <1% · 1 practitioner
  5. Internal Medicine $23 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $9,507 42% · 128 recipients
  2. Utah $3,746 16% · 56 recipients
  3. Wisconsin $1,964 9% · 42 recipients
  4. Texas $1,294 6% · 37 recipients
  5. Florida $1,086 5% · 19 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

15,325 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record